![Zachary Hornby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Zachary Hornby
Nessuna posizione attualmente
Patrimonio netto: 720 512 $ in data 31/08/2026
Profilo
Zachary D.
Hornby is Chief Executive Officer at Callio Therapeutics, Inc. since 2026.
Holds director positions at Independa, Inc., Radionetics Oncology, Inc., and Telperian, Inc. Serves as Chief Operating Officer at Ignyta Operating, Inc. since 2014.
Operating Partner at City Hill Ventures LLC.
Formerly President, Chief Executive Officer & Director at Boundless Bio, Inc. from 2019 to 2026.
Senior Director-Business Development at Fate Therapeutics, Inc. from 2010 to 2012.
Director-Business Development at Halozyme Therapeutics, Inc. from 2008 to 2010.
Director at Aardvark Therapeutics, Inc. and Novome Biotechnologies, Inc. Chief Operating Officer at Ignyta, Inc. from 2014 to 2018 and Chief Operating Officer & Vice President in 2018.
Business Development Associate at Shire Pharmaceuticals, Inc. Senior Manager-Products at Neurocrine Biosciences, Inc. from 2006 to 2008.
Life Sciences Consultant at The Lek.
Education includes undergraduate and graduate degrees from Stanford University in 2001 and an MBA from Harvard Business School in 2006.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
BOUNDLESS BIO INC. 1,13% | 20/04/2026 | 256.410 ( 1,13% ) | 720 512 $ | 31/08/2026 |
Posizioni attive di Zachary Hornby
| Società | Posizione | Inizio |
|---|---|---|
Ignyta Operating, Inc.
 Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular diagnostics for cancer and immunology | Direttore operativo | 01/08/2012 |
Independa, Inc.
 Independa, Inc. Packaged SoftwareTechnology Services Provides solutions that support independence as we age | Direttore/Membro del Consiglio | - |
City Hill Ventures LLC
 City Hill Ventures LLC Investment ManagersFinance City Hill Ventures invests in companies located in the United States. The firm focuses on biotechnology, clean technology and media & entertainment sectors and industries. It participates in seed, early and later stage capital requirements with an investment size ranging from USD 0.1 to 20 million. It also makes co- investments. | Investitore di Private Equity | - |
Radionetics Oncology, Inc.
 Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that discovers and develops novel radio therapeutics for the treatment of oncology indications | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Zachary Hornby
| Società | Posizione | Fine |
|---|---|---|
| BOUNDLESS BIO, INC. | Amministratore Delegato | 01/07/2026 |
| AARDVARK THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/05/2024 |
| IGNYTA INC | Direttore operativo | 01/07/2018 |
| IGNYTA INC | Direttore Finanziario/CFO | 30/05/2014 |
| FATE THERAPEUTICS, INC. | Investitore di Private Equity | 01/08/2012 |
Formazione di Zachary Hornby
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
58
Relazioni di 1° grado
15
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Independa, Inc.
Independa, Inc. Packaged SoftwareTechnology Services Provides solutions that support independence as we age | Technology Services |
Ignyta Operating, Inc.
Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular diagnostics for cancer and immunology | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Lek/Alcar Consulting Group, Inc.
 The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Commercial Services |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
City Hill Ventures LLC
City Hill Ventures LLC Investment ManagersFinance City Hill Ventures invests in companies located in the United States. The firm focuses on biotechnology, clean technology and media & entertainment sectors and industries. It participates in seed, early and later stage capital requirements with an investment size ranging from USD 0.1 to 20 million. It also makes co- investments. | Finance |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novome Biotechnologies, Inc.
 Novome Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell-based therapeutics through the engineering of commensal gut microbes | Commercial Services |
Aardvark Therapeutics, Inc.
 Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics for obesity and metabolic diseases | Health Technology |
Boundless Bio, Inc.
 Boundless Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that develops cancer therapeutics | Health Technology |
Radionetics Oncology, Inc.
Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that discovers and develops novel radio therapeutics for the treatment of oncology indications | Health Technology |
